A Study to Examine the Effect of Ginger on the Gut Microbiome (GINGER)

Overview

About this study

The purpose of this study is to estimate the impact of a 6‐week daily intake of 2000 mg of ginger extract on the composition of the gut microbiome using a randomized placebo-controlled double-blinded design; i.e., examine the change of microbiome over time within and between the subjects.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Colorectal adenoma diagnosis.

Exclusion Criteria:

Allergy or sensitivity to ginger.
Active cancer.
Unstable medical condition.
Unstable diet or weight.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Albert Lea, Minn. Mayo Clinic principal investigator Mina Hanna, M.D.	Closed for enrollment	Contact information: Cancer Center Clinical Trials Referral Office 855-776-0015

Mayo Clinic Location

Status

Contact

Albert Lea, Minn.

Mayo Clinic principal investigator

Mina Hanna, M.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

Clinical Trials